s, le ve u ct Estrogens (E) are involved in mucus secretion, lung changes in female hormones related to patient’s men-Lamas et al. BMC Pulmonary Medicine 2014, 14:165 http://www.biomedcentral.com/1471-2466/14/165Patient Registry. Post-puberty, the number of PE per year in males was 0.24 lower than in females. Below we present 2Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain Full list of author information is available at the end of the articledevelopment, expression of inflammation factors, and the risk of acquiring Pseudomonas aeruginosa (P. aeruginosa) including its conversion to the mucoid phenotype. In addition, E are also linked to increased activity of the so-dium channel and Na+-K−ATPase, a decrease in the ...
Background: Cystic Fibrosis (CF) is a hereditary pulmonary and extra-pulmonary disease that occurs ...
Abstract Background Among patients with cystic fibros...
Pulmonary arterial hypertension (PAH) is a complex disease characterized by elevated pulmonary arter...
Background: Women with cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas ae...
There is increasing evidence for sexual dimorphism of estrogen (E2) actions in the exacerbation of l...
8th Rapid Responses to Steroid Hormones Meeting, Lake Erie Coll Osteopath Med, Erie, PA, SEP 19-21, ...
Introduction: A ‘gender gap’ exists in cystic fibrosis (CF). Females acquire earlier microbial infec...
Idiopathic pulmonary arterial hypertension (PAH) is a disabling condition characterized by PA vasoco...
Gender has been shown to impact the prevalence of several lung diseases such as cancer, asthma, chro...
Non cystic-fibrosis bronchiectasis (NCFB) is a complex chronic respiratory disease, characterised by...
Pulmonary arterial hypertension (PAH) is a sexually dimorphic disease that affects women more than m...
2 | P a g e Several studies suggest that gender may affect cystic fibrosis (CF) disease severity, wi...
Background: Lymphangioleiomyomatosis (LAM), a rare progressive disease, is characterized by the prol...
A ‘gender gap ’ exists in Cystic Fibrosis (CF). Females acquire earlier microbial infections; have w...
Copyright © The Author(s), 2021. Non cystic-fibrosis bronchiectasis (NCFB) is a complex chronic resp...
Background: Cystic Fibrosis (CF) is a hereditary pulmonary and extra-pulmonary disease that occurs ...
Abstract Background Among patients with cystic fibros...
Pulmonary arterial hypertension (PAH) is a complex disease characterized by elevated pulmonary arter...
Background: Women with cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas ae...
There is increasing evidence for sexual dimorphism of estrogen (E2) actions in the exacerbation of l...
8th Rapid Responses to Steroid Hormones Meeting, Lake Erie Coll Osteopath Med, Erie, PA, SEP 19-21, ...
Introduction: A ‘gender gap’ exists in cystic fibrosis (CF). Females acquire earlier microbial infec...
Idiopathic pulmonary arterial hypertension (PAH) is a disabling condition characterized by PA vasoco...
Gender has been shown to impact the prevalence of several lung diseases such as cancer, asthma, chro...
Non cystic-fibrosis bronchiectasis (NCFB) is a complex chronic respiratory disease, characterised by...
Pulmonary arterial hypertension (PAH) is a sexually dimorphic disease that affects women more than m...
2 | P a g e Several studies suggest that gender may affect cystic fibrosis (CF) disease severity, wi...
Background: Lymphangioleiomyomatosis (LAM), a rare progressive disease, is characterized by the prol...
A ‘gender gap ’ exists in Cystic Fibrosis (CF). Females acquire earlier microbial infections; have w...
Copyright © The Author(s), 2021. Non cystic-fibrosis bronchiectasis (NCFB) is a complex chronic resp...
Background: Cystic Fibrosis (CF) is a hereditary pulmonary and extra-pulmonary disease that occurs ...
Abstract Background Among patients with cystic fibros...
Pulmonary arterial hypertension (PAH) is a complex disease characterized by elevated pulmonary arter...